LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2″ oxo-voruscharin and derivatives thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aro

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2,2:6,6-diethylen-3-oxo-17alpha-pregn-4-ene-21,17alpha-carbolact

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2-alkoxyestradiol analogs with antiproliferative and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2-alkoxyestradiol analogs with antiproliferative and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2-substituted pregna-1-3,5(10) triene and chola-1,3,5(10)...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2.beta.,19-ethylene bridged steroids as aromatase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

2.beta.,19-methyleneamino bridged steroids as aromatase inhibito

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

20-(B)-20,25-dihydroperoxy-3&bgr;-hydroxycholest-5-ene and...

Reissue Patent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

20-fluoro-17(20)-vinyl steroids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

20-Hydroperoxy cholesterol compounds for suppression of atheroge

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

20-keto-11.beta.-arylsteroids and their derivatives having agoni

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

20-Spiroxanes and analogues having an open ring E, processes for

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

20-substituted pregnene derivatives and their use as androgen sy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pha

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

21-chloro-pregnane derivative